✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

BioCryst Pharmaceuticals, Inc.

Common Name
BioCryst Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
435
Ticker
BCRX
Exchange
Nasdaq
Description
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing medicines for rare diseases, with a primary emphasis on hereditary angioedema (HAE). Its commercial ...

BioCryst Pharmaceuticals's Board and Committee Meetings Data

Explore BioCryst Pharmaceuticals's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2025
Board Meeting Count
6a
Audit Committee Meeting Count
4a
Compensation/Remuneration Committee Meeting Count
6a
Nomination Committee Meeting Count
5a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind BioCryst Pharmaceuticals’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. BioCryst Pharmaceuticals's DEF 14A 2025